Search for the latest oncology news by tumour type
Radio-wave therapy proves effective against liver cancer cells
A new targeted therapy using non-thermal radio waves has been shown to block the growth…
Browsing: Tumour Stream
ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma
A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and the Case…
ASCO 2019: New TAILORx data guides adjuvant therapy in younger breast cancer patients
New information about adjuvant therapy to prevent recurrence of breast cancer in women 50 years…
ASCO 2019: No benefit from pazopanib in advanced kidney cancer after surgery to remove metastases
The E2810 research study was conducted to determine whether taking the oral drug pazopanib following…
ASCO 2019: New standard regimen for women with uterine carcinosarcomas
Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin…
ASCO 2019: Patients who received PBI without chemotherapy experienced less fatigue, slightly poorer cosmesis
Patient-reported outcome (PRO) data indicates that partial breast irradiation (PBI) is more convenient than whole…
ASCO 2019: Men who choose active surveillance for early prostate cancer often don’t follow monitoring rules
Preliminary results from a University of North Carolina Lineberger Comprehensive Cancer Center study found that…
ASCO 2019: Use of broader criteria for clinical trial enrolment would double number of eligible patients with lung cancer
A study looking at 10,500 health records of advanced non-small cell lung cancer (aNSCLC) patients…
ASCO 2019: Colorectal cancer patients with liver metastases live just as long after laparoscopic surgery as open surgery
The randomised OSLO-COMET trial found that laparoscopic surgery did not change chances of survival, when…
ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced urothelial cancer
A single arm, phase II clinical trial of 125 patients showed treatment with enfortumab vedotin…